RYAH Group (CSE: RYAH) today announced its entry into a non-binding letter of intent (“LOI”) with Omni Services LLC (d/b/a “Omni Medical Services” or “Omni”), a leading physician-owned and operated telehealth, cannabis clinic and certifications company operating in the United States, with respect to the potential acquisition of 100% of the business and assets of Omni. The LOI, if consummated, is expected to combine Omni’s clinical research capabilities with the company’s IoT monitoring and control devices, and further the company’s ability to procure state and federal grants in the United States, which are reserved for the funding of clinical research studies focused on the advancement of plant medicine therapies. In particular, the transaction is expected to unite RYAH’s captive patient data platform with Omni’s approximately 20,000 U.S.-based medical cannabis patient network and tele-health solutions, to create a complete, closed-loop digital care ecosystem in plant-medicine therapies, from patient on-boarding, medicine administration, session monitoring and patient feedback. “Omni’s research expertise and network of certified physicians and patients will enable RYAH to develop new and innovative clinical studies, leveraging the ever-growing pool of funding designated for understanding the efficacy of plant-based therapies in the United States,” said RYAH CEO Gregory Wagner. “The complementary expertise that Omni and RYAH bring to the table is expected to accelerate our plans to be a U.S. and global market leader in the medical plant and nutraceutical intake industry, and generate significant value for our shareholders, partners, customers and patients.”
To view the full press release, visit https://cnw.fm/V3ouw
About RYAH Group Inc.
RYAH is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates Health Insurance Portability and Accountability Act (“HIPAA”)-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies and licensed processors (“LPs”) to monitor and manage formulation effects on patients and demographics. With a strong intellectual property portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation lifecycle. For more information, visit www.RYAHGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://cnw.fm/RYAH
About CanadianCannabisWire
CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.canadiancannabiswire.com
Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask our Editor
CanadianCannabisWire (CNW)
Toronto, Ontario
www.canadiancannabiswire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com
